Laszlo Urban is Global Head of Preclinical Safety Profiling at the Novartis Institutes for Biomedical Research (NIBR), Cambridge, Ma, and previously was the Deputy Head of the Novartis Institute for Medical Sciences in London, UK, an internationally recognized center of excellence for pain research.
He received his MD and PhD in neuropharmacology from Debrecen University, Hungary. He has published over 130 articles, book chapters and patents, edited 3 books and has served on the editorial board of several journals while also serving as President of the European Neuropeptide Club.
Since 2001, he has been leading a pharmaceutical research department developing methods and strategy for preclinical safety assessment.